Author Question: Chronic sorrow is: a. A response to the birth of a less than perfect infant that resolves as the ... (Read 85 times)

audie

  • Hero Member
  • *****
  • Posts: 532
Chronic sorrow is:
 a. A response to the birth of a less than perfect infant that resolves as the family adjusts to the changes in their lives
  b. A normal grief response that is associated with the day-to-day experience of living with what is versus the parents' view of what should have been
  c. An atypical grief response associated with conflicting cultural and personal values concerning disability
  d. A mild form of depression that often affects parents of both genders following the birth of a child

Question 2

Parents may have problems supporting attachment with their high-risk infant because:
 a. The infant has diminished ability to respond interactively
  b. Most medical care teams discourage this
  c. Their cultural beliefs support maintaining emotional distance from others
  d. The infant is too small



GCabra

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

b

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

Throughout history, plants containing cardiac steroids have been used as heart drugs and as poisons (e.g., in arrows used in combat), emetics, and diuretics.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library